Antiviral Group

About

The ISRV Antiviral Group (ISRV-AVG) was established as a special interest group of ISRV at the time of merger in April 2011 of the former Neuraminidase Inhibitor Susceptibility Network (NISN) with ISRV.

AVG’s Objectives

The AVG’s specific objectives are to promote understanding of the use of antivirals and other therapeutic strategies (antibodies, immunomodulators, drug combinations, etc) against respiratory virus infections. The group collates and provides up to date information and communicates expert commentary on the emergence of antiviral resistance as well as on preclinical and clinical development of potential novel/new therapeutics.

Principal activities and areas of interest of the AVG are listed under members’ interests.